vs
Astrana Health, Inc.（ASTH）とBLUE OWL CAPITAL INC.（OWL）の財務データ比較。上の社名をクリックして会社を切り替えられます
Astrana Health, Inc.の直近四半期売上が大きい（$950.5M vs $755.6M、BLUE OWL CAPITAL INC.の約1.3倍）。BLUE OWL CAPITAL INC.の純利益率が高く（6.3% vs 0.7%、差は5.6%）。Astrana Health, Inc.の前年同期比売上増加率が高い（42.9% vs 19.7%）。BLUE OWL CAPITAL INC.の直近四半期フリーキャッシュフローが多い（$359.1M vs $-6.0M）。過去8四半期でAstrana Health, Inc.の売上複合成長率が高い（53.3% vs 21.3%）
アストラナヘルス社は米国に本拠を置く価値基準型医療サービスプロバイダーで、主に米国全土の連邦医療保険対象高齢者層にサービスを提供している。訪問型プライマリケア、慢性疾患管理、ケアコーディネーションを通じ、患者の健康状態改善と不要な医療費削減を目指している。
ブルーオウル・キャピタル社は米国のオルタナティブ投資向け資産運用会社で、ニューヨーク証券取引所に銘柄コード「OWL」で上場しています。本社をニューヨークに置き、ロンドン、ドバイ、香港などにも拠点を構え、グローバルに事業を展開しています。
ASTH vs OWL — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $950.5M | $755.6M |
| 純利益 | $6.6M | $47.7M |
| 粗利率 | — | — |
| 営業利益率 | 1.9% | 22.2% |
| 純利益率 | 0.7% | 6.3% |
| 売上前年比 | 42.9% | 19.7% |
| 純利益前年比 | 184.4% | 129.8% |
| EPS（希薄化後） | $0.12 | $0.07 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $950.5M | $755.6M | ||
| Q3 25 | $956.0M | $728.0M | ||
| Q2 25 | $654.8M | $703.1M | ||
| Q1 25 | $620.4M | $683.5M | ||
| Q4 24 | $665.2M | $631.4M | ||
| Q3 24 | $478.7M | $600.9M | ||
| Q2 24 | $486.3M | $549.8M | ||
| Q1 24 | $404.4M | $513.3M |
| Q4 25 | $6.6M | $47.7M | ||
| Q3 25 | $373.0K | $6.3M | ||
| Q2 25 | $9.4M | $17.4M | ||
| Q1 25 | $6.7M | $7.4M | ||
| Q4 24 | $-7.8M | $20.7M | ||
| Q3 24 | $16.1M | $29.8M | ||
| Q2 24 | $19.2M | $33.9M | ||
| Q1 24 | $14.8M | $25.1M |
| Q4 25 | 1.9% | 22.2% | ||
| Q3 25 | 2.0% | 7.6% | ||
| Q2 25 | 3.1% | 12.0% | ||
| Q1 25 | 3.3% | 5.9% | ||
| Q4 24 | 0.1% | 11.7% | ||
| Q3 24 | 5.9% | 18.7% | ||
| Q2 24 | 6.2% | 28.4% | ||
| Q1 24 | 7.5% | 24.7% |
| Q4 25 | 0.7% | 6.3% | ||
| Q3 25 | 0.0% | 0.9% | ||
| Q2 25 | 1.4% | 2.5% | ||
| Q1 25 | 1.1% | 1.1% | ||
| Q4 24 | -1.2% | 3.3% | ||
| Q3 24 | 3.4% | 5.0% | ||
| Q2 24 | 3.9% | 6.2% | ||
| Q1 24 | 3.7% | 4.9% |
| Q4 25 | $0.12 | $0.07 | ||
| Q3 25 | $0.01 | $0.01 | ||
| Q2 25 | $0.19 | $0.02 | ||
| Q1 25 | $0.14 | $0.00 | ||
| Q4 24 | $-0.14 | $0.06 | ||
| Q3 24 | $0.33 | $0.04 | ||
| Q2 24 | $0.40 | $0.06 | ||
| Q1 24 | $0.31 | $0.04 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $429.5M | $194.5M |
| 総負債低いほど良い | — | $3.3B |
| 株主資本純資産 | $779.3M | $2.2B |
| 総資産 | $2.2B | $12.5B |
| 負債/資本比率低いほどレバレッジが低い | — | 1.51× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $429.5M | $194.5M | ||
| Q3 25 | $463.4M | $137.3M | ||
| Q2 25 | $342.1M | $117.6M | ||
| Q1 25 | $260.9M | $97.6M | ||
| Q4 24 | $290.8M | $152.1M | ||
| Q3 24 | $350.3M | $115.9M | ||
| Q2 24 | $327.7M | $436.8M | ||
| Q1 24 | $337.3M | $155.8M |
| Q4 25 | — | $3.3B | ||
| Q3 25 | — | $3.2B | ||
| Q2 25 | — | $3.2B | ||
| Q1 25 | — | $3.2B | ||
| Q4 24 | — | $2.6B | ||
| Q3 24 | — | $2.5B | ||
| Q2 24 | — | $2.5B | ||
| Q1 24 | — | $2.1B |
| Q4 25 | $779.3M | $2.2B | ||
| Q3 25 | $775.5M | $2.3B | ||
| Q2 25 | $765.5M | $2.4B | ||
| Q1 25 | $745.4M | $2.3B | ||
| Q4 24 | $712.7M | $2.1B | ||
| Q3 24 | $704.6M | $2.0B | ||
| Q2 24 | $678.9M | $1.7B | ||
| Q1 24 | $653.5M | $1.6B |
| Q4 25 | $2.2B | $12.5B | ||
| Q3 25 | $2.2B | $12.5B | ||
| Q2 25 | $1.4B | $12.3B | ||
| Q1 25 | $1.3B | $12.3B | ||
| Q4 24 | $1.4B | $11.0B | ||
| Q3 24 | $1.3B | $10.8B | ||
| Q2 24 | $1.3B | $9.7B | ||
| Q1 24 | $1.2B | $9.0B |
| Q4 25 | — | 1.51× | ||
| Q3 25 | — | 1.41× | ||
| Q2 25 | — | 1.38× | ||
| Q1 25 | — | 1.37× | ||
| Q4 24 | — | 1.22× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | — | 1.41× | ||
| Q1 24 | — | 1.26× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $-2.9M | $382.9M |
| フリーキャッシュフロー営業CF - 設備投資 | $-6.0M | $359.1M |
| FCFマージンFCF / 売上 | -0.6% | 47.5% |
| 設備投資強度設備投資 / 売上 | 0.3% | 3.1% |
| キャッシュ転換率営業CF / 純利益 | -0.44× | 8.03× |
| 直近12ヶ月FCF直近4四半期 | $104.5M | $1.2B |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $-2.9M | $382.9M | ||
| Q3 25 | $10.0M | $433.1M | ||
| Q2 25 | $90.9M | $422.5M | ||
| Q1 25 | $16.6M | $17.6M | ||
| Q4 24 | $-10.9M | $324.0M | ||
| Q3 24 | $34.0M | $326.0M | ||
| Q2 24 | $23.2M | $302.3M | ||
| Q1 24 | $6.0M | $47.2M |
| Q4 25 | $-6.0M | $359.1M | ||
| Q3 25 | $7.4M | $422.5M | ||
| Q2 25 | $89.5M | $412.5M | ||
| Q1 25 | $13.6M | $4.2M | ||
| Q4 24 | $-13.5M | $310.1M | ||
| Q3 24 | $31.7M | $314.8M | ||
| Q2 24 | $20.4M | $269.4M | ||
| Q1 24 | $5.6M | $41.1M |
| Q4 25 | -0.6% | 47.5% | ||
| Q3 25 | 0.8% | 58.0% | ||
| Q2 25 | 13.7% | 58.7% | ||
| Q1 25 | 2.2% | 0.6% | ||
| Q4 24 | -2.0% | 49.1% | ||
| Q3 24 | 6.6% | 52.4% | ||
| Q2 24 | 4.2% | 49.0% | ||
| Q1 24 | 1.4% | 8.0% |
| Q4 25 | 0.3% | 3.1% | ||
| Q3 25 | 0.3% | 1.5% | ||
| Q2 25 | 0.2% | 1.4% | ||
| Q1 25 | 0.5% | 2.0% | ||
| Q4 24 | 0.4% | 2.2% | ||
| Q3 24 | 0.5% | 1.9% | ||
| Q2 24 | 0.6% | 6.0% | ||
| Q1 24 | 0.1% | 1.2% |
| Q4 25 | -0.44× | 8.03× | ||
| Q3 25 | 26.69× | 68.64× | ||
| Q2 25 | 9.65× | 24.25× | ||
| Q1 25 | 2.48× | 2.37× | ||
| Q4 24 | — | 15.62× | ||
| Q3 24 | 2.11× | 10.94× | ||
| Q2 24 | 1.21× | 8.91× | ||
| Q1 24 | 0.40× | 1.88× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
OWL
| Credit Platform | $455.0M | 60% |
| GP Strategic Capital Platform | $157.0M | 21% |
| Administrative Service | $87.6M | 12% |
| IPI Partners LLC | $33.8M | 4% |
| Other | $22.2M | 3% |
